FDAFDA · Food and drugs·Recall number D-0288-2021
Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50
Published March 3, 2021 · Recall initiated: February 17, 2021
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Telephone
Recall details
- Brand
- FLUDEOXYGLUCOSE F 18
- Manufacturer
- The General Hospital Corporation
- Distributor
- Product was distributed to one direct account.
- Lot
- Lot # P01-021721, exp 02/17/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.